New Drug Application

Marketing application submissions, including NDAs, biologics license applications (BLAs), and premarket approvals (PMAs) in the US, are the culmination of years of research and the final hurdle before a product makes it to market. During this webinar, experts David Shoemaker, Ph. D, senior vice president, research and development and Rob Woolson, J.D., M.S., chief strategist, biostatistics and data standards for regulatory submissions at Rho will help you navigate submissions in the most efficient and effective way.